ऑस्ट्रेलिया - अंग्रेज़ी - Department of Health (Therapeutic Goods Administration)

cipla australia pty ltd - salmeterol xinafoate, quantity: 36.32 microgram/actuation (equivalent: salmeterol, qty 25 microgram/actuation); fluticasone propionate, quantity: 125 microgram/actuation - inhalation, pressurised - excipient ingredients: norflurane - for the regular treatment of asthma, where the use of a combination product is appropriate. this may include: - patients on effective maintenance doses of long-acting beta-2 agonists and inhaled corticosteroids. - patients who are symptomatic on current inhaled corticosteroid therapy.,for the symptomatic treatment of patients with severe copd (fev1 less than 50 precent predicted normal) and a history of repeated exacerbations who have significant symptoms despite regular beta-2 agonist bronchodilator therapy. fluticasone propionate/salmeterol (125 microgram/25 microgram and 250 microgram/25 microgram) is not indicated for the initiation of bronchodilator therapy in copd.

स्पेन - स्पेनी - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

cipla europe nv - salmeterol xinafoato; fluticasona propionato - suspensiÓn para inhalaciÓn en envase a presiÓn - 25 microgramos/125 microgramos - salmeterol xinafoato 25 microgramos; fluticasona propionato 125 microgramos - salmeterol y fluticasona

स्पेन - स्पेनी - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

cipla europe nv - salmeterol xinafoato; fluticasona propionato - suspensiÓn para inhalaciÓn en envase a presiÓn - 25 microgramos/250 microgramos - salmeterol xinafoato 25 microgramos; fluticasona propionato 250 microgramos - salmeterol y fluticasona

स्पेन - स्पेनी - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

cipla europe nv - salmeterol xinafoato; fluticasona propionato - polvo para inhalaciÓn (unidosis) - 50 microgramos/250 microgramos/dosis - salmeterol xinafoato 50 microgramos; fluticasona propionato 250 microgramos - salmeterol y fluticasona

स्पेन - स्पेनी - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

cipla europe nv - salmeterol xinafoato; fluticasona propionato - polvo para inhalaciÓn (unidosis) - 50 microgramos/500 microgramos/dosis - salmeterol xinafoato 50 microgramos; fluticasona propionato 500 microgramos - salmeterol y fluticasona

नीदरलैंड - डच - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

dr. fisher farma b.v. - salmeterolxinafoaat samenstelling overeenkomend met; salmeterol; - aërosol, suspensie - salmeterol

संयुक्त राज्य - अंग्रेज़ी - NLM (National Library of Medicine)

proficient rx lp - fluticasone propionate (unii: o2gmz0lf5w) (fluticasone - unii:cut2w21n7u), salmeterol xinafoate (unii: 6ew8q962a5) (salmeterol - unii:2i4bc502bt) - fluticasone propionate/salmeterol diskus is indicated for the twice-daily treatment of asthma in patients aged 4 years and older. fluticasone propionate/salmeterol diskus should be used for patients not adequately controlled on a long-term asthma control medication such as an inhaled corticosteroid (ics) or whose disease warrants initiation of treatment with both an ics and long-acting beta2 -adrenergic agonist (laba). important limitation of use fluticasone propionate/salmeterol diskus is not indicated for the relief of acute bronchospasm. fluticasone propionate/salmeterol diskus inhalation powder 250/50 mcg is indicated for the twice-daily maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (copd), including chronic bronchitis and/or emphysema. fluticasone propionate/salmeterol diskus inhalation powder 250/50 mcg is also indicated to reduce exacerbations of copd in patients with a history of exacerbations. fluticasone propionate/salmeterol diskus inhalation po

नीदरलैंड - डच - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

sandoz b.v. veluwezoom 22 1327 ah almere - fluticasonpropionaat ; salmeterolxinafoaat samenstelling overeenkomend met ; salmeterol - aërosol, suspensie - norfluraan, - salmeterol and fluticasone

नीदरलैंड - डच - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

sandoz b.v. veluwezoom 22 1327 ah almere - fluticasonpropionaat ; salmeterolxinafoaat samenstelling overeenkomend met ; salmeterol - aërosol, suspensie - norfluraan, - salmeterol and fluticasone

नीदरलैंड - डच - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

glaxosmithkline b.v. - fluticasonpropionaat; salmeterolxinafoaat samenstelling overeenkomend met; salmeterol; - inhalatiepoeder, voorverdeeld - salmeterol and fluticasone